US2008227172A1PendingUtilityA1
Sialyltransferase and dna encoding the same
Est. expiryJul 9, 2017(expired)· nominal 20-yr term from priority
Inventors:Masaki Saito
C12N 9/1081
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A sialyltransferase having the following physico-chemical properties: (1) Activity; transfers sialic acid from a sialic acid donor selectively to a 3-hydroxyl group of a galactose residue contained in lactosylceramide as a sialic acid acceptor to produce ganglioside G M3 ; (2) Optimal reaction pH: 6.0 to 7.0; and (3) Inhibition and activation: the activity increases at least 1.5 times with 10 mM of Mn 2+ as compared with the case in the absence thereof.
Claims
exact text as granted — not AI-modified1 . An isolated sialyltransferase having the following physico-chemical properties:
(1) Activity:
transfers sialic acid from a sialic acid donor selectively to a 3-hydroxyl group of a galactose residue contained in lactosylceramide as a sialic acid acceptor to produce ganglioside G M3 ;
(2) Optimal reaction pH:
6.0 to 7.0; and
(3) Activation:
the activity increases at least 1.5 times with 10 mM of Mn 2+ as compared with the case in the absence thereof.
2 . The isolated sialyltransferase of claim 1 having a C-terminal amino acid sequence shown by SEQ ID NO: 5.
3 . The isolated sialyltransferase of claim 1 comprising the amino acid sequence shown by SEQ ID NO: 6.
4 . The isolated sialyltransferase of claim 1 comprising the amino acid sequence shown by SEQ ID NO: 12.
5 . The sialyltransferase according to claim 4 , wherein said sialyltransferase is derived from human.
6 . The sialyltransferase according to claim 1 , wherein said sialic acid donor is cytidine 5′-monophosphate-sialic acid (CMP-sialic acid).
7 . The sialyltransferase according to claim 1 , wherein said sialyltransferase is derived from human.
8 . The isolated sialyltransferase of claim 1 comprising a polypeptide having an amino acid sequence selected from the group consisting of:
(a) the amino acid sequence shown by SEQ ID NO: 2, and (b) the amino acid sequence shown by SEQ ID NO: 2, which has therein substitution, deletion, insertion or rearrangement of one or a few amino acid residues.
9 . The isolated sialyltransferase of claim 1 comprising a polypeptide, wherein said polypeptide has an amino acid sequence with not less than 65% homology with an amino acid sequence shown by SEQ ID NO: 8.
10 . The isolated sialyltransferase of claim 1 having no transmembrane domain.
11 . The sialyltransferase according to claim 10 , wherein said sialyltransferase has an amino acid sequence comprising SEQ ID NO: 8 with a transmembrane domain deletion.
12 . The isolated sialyltransferase of claim 8 having the amino acid sequence of amino acid numbers 38 to 359 in the amino acid sequence shown by SEQ ID NO: 2.
13 - 21 . (canceled)
22 . The isolated sialyltransferase of claim 1 comprising the amino acid sequence of amino acid numbers 41 to 362 in the amino acid sequence shown by SEQ ID NO: 8.
23 . The sialyltransferase according to claim 22 , which comprises the amino acid sequence of amino acid numbers 1 to 362 in amino acid sequence shown by SEQ ID NO: 8.
24 . (canceled)
25 . The isolated sialyltransferase of claim 1 comprising an amino acid sequence shown by SEQ ID NO: 11.
26 . An isolated polypeptide comprising an amino acid sequence of amino acid numbers 41 to 362 in amino acid sequence shown by SEQ ID NO: 8.
27 . An isolated polypeptide comprising an amino acid sequence of amino acid numbers 1 to 362 in amino acid sequence shown by SEQ ID NO: 8.
28 - 43 . (canceled)Join the waitlist — get patent alerts
Track US2008227172A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.